Stock Price
2.20
Daily Change
3.29%
Yearly
-27.87%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Astellas Pharma 1,931.50 63.00 3.37% 16.25%
Acadia Pharmaceuticals 23.05 0.91 4.11% -57.04%
Agios Pharmaceuticals 33.14 1.19 3.72% -27.44%
Akebia Therapeutics 2.20 0.07 3.29% -27.87%
Alnylam Pharmaceuticals 148.50 0.50 0.34% -10.74%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 235.36 4.51 1.95% -4.13%
Ardelyx 0.93 0.01 0.82% -86.33%
Avrobio Inc 2.06 0 0% -85.68%
AstraZeneca 8,544.00 95.00 1.12% 12.54%
Bayer 52.59 1.53 3.00% 0.65%
BioMarin Pharmaceutical 90.22 2.06 2.34% 8.74%
Exelixis 18.12 0.35 1.97% -23.62%
Fresenius Medical Care 58.96 1.22 2.11% -14.28%
GlaxoSmithKline 1,641.00 9.80 0.60% 16.09%
Intercept Pharmaceuticals 17.76 1.31 7.96% -35.30%
Ionis Pharmaceuticals 33.08 0.95 2.96% -46.02%
Ironwood Pharmaceuticals 11.72 0.36 3.17% 6.26%
J&J 167.84 -0.92 -0.55% 4.70%
Karyopharm Therapeutics 8.04 0.01 0.12% -46.18%
Lexicon Pharmaceuticals 3.45 0.06 1.77% -49.78%
Moderna Inc 204.73 -5.44 -2.59% 57.91%
Nektar Therapeutics 12.10 0.10 0.83% -28.74%
Opko Health 4.53 0.25 5.84% -0.44%
Prothena 39.53 2.29 6.15% 190.88%
PTC Therapeutics 43.75 1.52 3.60% -36.12%
Regeneron Pharmaceuticals 615.24 -0.87 -0.14% 18.79%
Roche Holding 365.00 2.85 0.79% 15.27%
Sanofi 90.62 1.70 1.91% 11.15%
Seattle Genetics 137.09 0.30 0.22% -26.20%
Sarepta Therapeutics 71.10 -1.29 -1.78% -21.28%
Vanda Pharmaceuticals 15.00 0.49 3.38% 9.25%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
NASDAQ 14894 86.94 0.59% 14.58%
US2000 2162 3.02 0.14% 1.85%

Akebia Therapeutics
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on producing medicines for people living with kidney disease. Its lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), designed to mimic the physiologic effect of altitude on oxygen availability. In addition, it has a commercial product, Auryxia (ferric citrate), which is marketed for two indications in the United States: the control of serum phosphorus levels in dialysis-dependent (DD)-CKD adult patients and the treatment of iron deficiency anemia (IDA), in non-dialysis dependent (NDD)-CKD adult patients. Ferric citrate is also approved and marketed in Japan as an oral treatment for the improvement of hyperphosphatemia in patients with CKD.